Osteologie 2011; 20(04): 327
DOI: 10.1055/s-0037-1620023
Vitamin D
Schattauer GmbH

Literatur

S. Pilz
Further Information

Publication History

Publication Date:
30 December 2017 (online)

 

 
  • Literatur

  • 1 Pilz S, Tomaschitz A, Pieber TR. et al. Vitamin D: clinical applications beyond musculoskeletal diseases. J Lab Med 2011; 35: 211-216.
  • 2 Souberbielle JC, Body JJ, Lappe JM. et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice. Autoimmun Rev 2010; 09: 709-715.
  • 3 Bouillon R, Carmeliet G, Verlinden L. et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 2008; 29: 726-776.
  • 4 Grant WB, Mohr SB. Ecological studies of ultraviolet B, vitamin D and cancer since 2000. Ann Epidemiol 2009; 19: 446-454.
  • 5 Pilz S, Tomaschitz A, Obermayer-Pietsch B. et al. Epidemiology of vitamin D insufficiency and cancer mortality. Anticancer Res 2009; 29: 3699-3704.
  • 6 Deeb KK, Trump DL, Johnson CS. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 2007; 07: 684-700.
  • 7 Pilz S, Dobnig H, Winklhofer-Roob B. et al. Low serum levels of 25-hydroxyvitamin D predict fatal cancer in patients referred to coronary angiography. Cancer Epidemiol Biomarkers Prev 2008; 17: 1228-1233.
  • 8 Touvier M, Chan DS, Lau RN. et al. Meta-analyses of vitamin D intake, 25-hydroxyvitamin D status, vitamin D receptor polymorphisms and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2011; 20: 1003-1016.
  • 9 Helzlsouer KJ. VDPP Steering Committee. Overview of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol 2010; 172: 4-9.
  • 10 Manson JE, Mayne ST, Clinton SK. Vitamin D and prevention of cancer – ready for prime time?. N Engl J Med 2011; 364: 1385-1387.
  • 11 Wactawski-Wende J, Kotchen JM, Anderson GL. et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 2006; 354: 684-696.
  • 12 Lappe JM, Travers-Gustafson D, Davies KM. et al. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007; 85: 1586-1591.
  • 13 Adams JS, Hewison M. Update in vitamin D. J Clin Endocrinol Metab 2010; 95: 471-478.
  • 14 Schleithoff SS, Zittermann A, Tenderich G. et al. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 2006; 83: 754-759.
  • 15 van Etten E, Stoffels K, Gysemans C. et al. Regulation of vitamin D homeostasis: implications for the immune system. Nutr Rev 2008; 66 (10 Suppl 2): S125-S134.
  • 16 Prietl B, Pilz S, Wolf M. et al. Vitamin D supplementation and regulatory T cells in apparently healthy subjects: vitamin D treatment for autoimmune diseases?. Isr Med Assoc J 2010; 12: 136-139.
  • 17 Bock G, Prietl B, Mader JK. et al. The effect of vitamin D supplementation on peripheral regulatory T cells and ß cell function in healthy humans : a randomized controlled trial. Diabetes Metab Res Rev. 2011 in press.
  • 18 Hyppönen E, Läärä E, Reunanen A. et al. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001; 358: 1500-1503.
  • 19 Cooper JD, Smyth DJ, Walker NM. et al. Inherited variation in vitamin D genes is associated with predisposition to autoimmune disease type 1 diabetes. Diabetes 2011; 60: 4-1631.
  • 20 Kimball S, Vieth R, Dosch HM. et al. Cholecalciferol Plus Calcium Suppresses Abnormal PBMC Reactivity in Patients with Multiple Sclerosis. J Clin Endocrinol Metab. in press.
  • 21 Burton JM, Kimball S, Vieth R. et al. A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis. Neurology 2010; 74: 1852-1859.
  • 22 Hewison M. Antibacterial effects of vitamin D. Nat Rev Endocrinol 2011; 07: 337-345.
  • 23 Schwalfenberg GK. A review of the critical role of vitamin D in the functioning of the immune system and the clinical implications of vitamin D deficiency. Mol Nutr Food Res 2011; 55: 96-108.
  • 24 Martineau AR, Timms PM, Bothamley GH. et al. High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet 2011; 377: 242-250.
  • 25 Urashima M, Segawa T, Okazaki M. et al. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr 2010; 91: 1255-1260.
  • 26 Gal-Tanamy M, Bachmetov L, Ravid A. et al. Vitamin-D: An innate antiviral agent suppressing Hepatitis C virus in human hepatocytes. Hepatology. 2011 Jul 25. [Epub ahead of print]; doi: 10.1002/hep.24575.
  • 27 Bitetto D, Fattovich G, Fabris C. et al. Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C. Hepatology 2011; 53: 1118-1126.
  • 28 Lewis S, Lucas RM, Halliday J, Ponsonby AL. Vitamin D deficiency and pregnancy: from preconception to birth. Mol Nutr Food Res 2010; 54: 1092-1102.
  • 29 Stewart A, Wong K, Cachat J. et al. Neurosteroid vitamin D system as a nontraditional drug target in neuropsychopharmacology. Behav Pharmacol 2010; 21: 420-426.
  • 30 Pilz S, Tomaschitz A, Drechsler C. et al. Vitamin D supplementation: a promising approach for the prevention and treatment of strokes. Curr Drug Targets 2011; 12: 88-96.
  • 31 Pilz S, Dobnig H, Fischer JE. et al. Low vitamin D levels predict stroke in patients referred to coronary angiography. Stroke 2008; 39: 2611-2613.
  • 32 Elamin MB, Abu NOElnour, Elamin KB. et al. Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. J Clin Endocrinol Metab 2011; 96: 1931-1942.
  • 33 Pilz S, Tomaschitz A, März W. et al. Vitamin D, cardiovascular disease and mortality. Clin Endocrinol (Oxf) 2011; 75: 575-584.
  • 34 Pilz S, Frisch S, Koertke H. et al. Effect of vitamin D supplementation on testosterone levels in men. Horm Metab Res 2011; 43: 223-225.
  • 35 Wehr E, Pilz S, Boehm BO. et al. Association of vitamin D status with serum androgen levels in men. Clin Endocrinol (Oxf) 2010; 73: 243-248.
  • 36 Ross AC, Manson JE, Abrams SA. et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011; 96: 53-58.
  • 37 Holick MF, Binkley NC, Bischoff-Ferrari HA. et al. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 1911-1930.
  • 38 Hathcock JN, Shao A, Vieth R, Heaney RP. Risk assessment for vitamin D. Am J Clin Nutr 2007; 85: 6-18.
  • 39 Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 2007; 167: 1730-1737.
  • 40 Bjelakovic G, Gluud LL, Nikolova D. et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 2011; 07: CD007470.
  • 41 v. Domarus C, Amling M. Volkswirtschaftliche Bedeutung einer Vitamin-D-Anreicherung von Lebensmitteln. Osteologie 2009; 18: 112-124.